{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T19:54:54Z","timestamp":1794599694730,"version":"4.9.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01-AG07757"],"award-info":[{"award-number":["R01-AG07757"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A key hallmark of Parkinson\u2019s disease (PD) is Lewy pathology. Composed of \u03b1-synuclein, Lewy pathology is found both in dopaminergic neurons that modulate motor function, and cortical regions that control cognitive function. Recent work has established the molecular identity of dopaminergic neurons susceptible to death, but little is known about cortical neurons susceptible to Lewy pathology or molecular changes induced by aggregates. In the current study, we use spatial transcriptomics to capture whole transcriptome signatures from cortical neurons with \u03b1-synuclein pathology compared to neurons without pathology. We find, both in PD and related PD dementia, dementia with Lewy bodies and in the pre-formed fibril \u03b1-synucleinopathy mouse model, that specific classes of excitatory neurons are vulnerable to developing Lewy pathology. Further, we identify conserved gene expression changes in aggregate-bearing neurons that we designate the Lewy-associated molecular dysfunction from aggregates (LAMDA) signature. Neurons with aggregates downregulate synaptic, mitochondrial, ubiquitin-proteasome, endo-lysosomal, and cytoskeletal genes and upregulate DNA repair and complement\/cytokine genes. Our results identify neurons vulnerable to Lewy pathology in the PD cortex and describe a conserved signature of molecular dysfunction in both mice and humans.<\/jats:p>","DOI":"10.1038\/s41467-024-47027-8","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T02:15:00Z","timestamp":1711419300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2625-9195","authenticated-orcid":false,"given":"Thomas M.","family":"Goralski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Meyerdirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libby","family":"Breton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Brasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3237-7390","authenticated-orcid":false,"given":"Kevin","family":"Kurgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"DeWeerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3586-8566","authenticated-orcid":false,"given":"Lisa","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7909-2339","authenticated-orcid":false,"given":"Marie","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Newhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9710-0726","authenticated-orcid":false,"given":"Michael X.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"47027_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"47027_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00441-018-2854-6","volume":"373","author":"S Chartier","year":"2018","unstructured":"Chartier, S. & Duyckaerts, C. Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity? Cell Tissue Res. 373, 149\u2013160 (2018).","journal-title":"Cell Tissue Res."},{"key":"47027_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Prim. 7, 47 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"47027_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jns.2006.05.011","volume":"248","author":"H Braak","year":"2006","unstructured":"Braak, H., Rub, U. & Del Tredici, K. Cognitive decline correlates with neuropathological stage in Parkinson\u2019s disease. J. Neurol. Sci. 248, 255\u2013258 (2006).","journal-title":"J. Neurol. Sci."},{"key":"47027_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin, D. J. et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol. 16, 55\u201365 (2017).","journal-title":"Lancet Neurol."},{"key":"47027_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin, D. J. et al. Neuropathologic substrates of Parkinson disease dementia. Ann. Neurol. 72, 587\u2013598 (2012).","journal-title":"Ann. Neurol."},{"key":"47027_CR7","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/acn3.50857","volume":"6","author":"L Yu","year":"2019","unstructured":"Yu, L. et al. Common age-related neuropathologies and yearly variability in cognition. Ann. Clin. Transl. Neurol. 6, 2140\u20132149 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"47027_CR8","first-page":"1234","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith, C. et al. Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J. Neurol., Neurosurg. Psychiatry 90, 1234\u20131243 (2019).","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"47027_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fneur.2018.00455","volume":"9","author":"N Giguere","year":"2018","unstructured":"Giguere, N., Burke Nanni, S. & Trudeau, L. E. On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease. Front. Neurol. 9, 455 (2018).","journal-title":"Front. Neurol."},{"key":"47027_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier, D. J., Obeso, J. A. & Halliday, G. M. Selective neuronal vulnerability in Parkinson disease. Nat. Rev. Neurosci. 18, 101\u2013113 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"47027_CR11","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier, P., Hirsch, E. C., Agid, Y. & Graybiel, A. M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain: a J. Neurol. 122, 1437\u20131448 (1999).","journal-title":"Brain: a J. Neurol."},{"key":"47027_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0967-5868(96)90083-1","volume":"3","author":"GM Halliday","year":"1996","unstructured":"Halliday, G. M. et al. Midbrain neuropathology in idiopathic Parkinson\u2019s disease and diffuse Lewy body disease. J. Clin. Neurosci. 3, 52\u201360 (1996).","journal-title":"J. Clin. Neurosci."},{"key":"47027_CR13","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath, T. et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat. Neurosci. 25, 588\u2013595 (2022).","journal-title":"Nat. Neurosci."},{"key":"47027_CR14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smajic","year":"2022","unstructured":"Smajic, S. et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain 145, 964\u2013978 (2022).","journal-title":"Brain"},{"key":"47027_CR15","doi-asserted-by":"publisher","first-page":"eadi8287","DOI":"10.1126\/sciadv.adi8287","volume":"10","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson\u2019s disease. Sci. Adv. 10, eadi8287 (2024).","journal-title":"Sci. Adv."},{"key":"47027_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"47027_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/nan.12501","volume":"45","author":"YY Fathy","year":"2019","unstructured":"Fathy, Y. Y. et al. Differential insular cortex subregional vulnerability to alpha-synuclein pathology in Parkinson\u2019s disease and dementia with Lewy bodies. Neuropathol. Appl. Neurobiol. 45, 262\u2013277 (2019).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"47027_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JAD-2006-9S305","volume":"9","author":"H Braak","year":"2006","unstructured":"Braak, H., Rub, U., Schultz, C. & Del Tredici, K. Vulnerability of cortical neurons to Alzheimer\u2019s and Parkinson\u2019s diseases. J. Alzheimers Dis. 9, 35\u201344 (2006).","journal-title":"J. Alzheimers Dis."},{"key":"47027_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s004010000270","volume":"101","author":"E Gomez-Tortosa","year":"2001","unstructured":"Gomez-Tortosa, E., Sanders, J. L., Newell, K. & Hyman, B. T. Cortical neurons expressing calcium binding proteins are spared in dementia with Lewy bodies. Acta Neuropathol. 101, 36\u201342 (2001).","journal-title":"Acta Neuropathol."},{"key":"47027_CR20","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/mds.22184","volume":"23","author":"C Stamper","year":"2008","unstructured":"Stamper, C. et al. Neuronal gene expression correlates of Parkinson\u2019s disease with dementia. Mov. Disord. 23, 1588\u20131595 (2008).","journal-title":"Mov. Disord."},{"key":"47027_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00401-021-02343-x","volume":"142","author":"R Feleke","year":"2021","unstructured":"Feleke, R. et al. Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases. Acta Neuropathol. 142, 449\u2013474 (2021).","journal-title":"Acta Neuropathol."},{"key":"47027_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/978-1-0716-0623-0_21","volume":"2148","author":"DR Zollinger","year":"2020","unstructured":"Zollinger, D. R., Lingle, S. E., Sorg, K., Beechem, J. M. & Merritt, C. R. GeoMx RNA Assay: High multiplex, digital, spatial analysis of RNA in FFPE tissue. Methods Mol. Biol. 2148, 331\u2013345 (2020).","journal-title":"Methods Mol. Biol."},{"key":"47027_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/B978-0-444-64196-0.00013-3","volume":"166","author":"BA Vogt","year":"2019","unstructured":"Vogt, B. A. Cingulate cortex in Parkinson\u2019s disease. Handb. Clin. Neurol. 166, 253\u2013266 (2019).","journal-title":"Handb. Clin. Neurol."},{"key":"47027_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach, T. G. et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol. 117, 613\u2013634 (2009).","journal-title":"Acta Neuropathol."},{"key":"47027_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"47027_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2012.02.052","volume":"149","author":"H Zeng","year":"2012","unstructured":"Zeng, H. et al. Large-scale cellular-resolution gene profiling in human neocortex reveals species-specific molecular signatures. Cell 149, 483\u2013496 (2012).","journal-title":"Cell"},{"key":"47027_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"47027_CR28","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"47027_CR29","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"47027_CR30","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949\u2013953 (2012).","journal-title":"Science"},{"key":"47027_CR31","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","volume":"22","author":"MX Henderson","year":"2019","unstructured":"Henderson, M. X. et al. Spread of alpha-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis. Nat. Neurosci. 22, 1248\u20131257 (2019).","journal-title":"Nat. Neurosci."},{"key":"47027_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57\u201371 (2011).","journal-title":"Neuron"},{"key":"47027_CR33","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.celrep.2015.01.060","volume":"10","author":"VR Osterberg","year":"2015","unstructured":"Osterberg, V. R. et al. Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism. Cell Rep. 10, 1252\u20131260 (2015).","journal-title":"Cell Rep."},{"key":"47027_CR34","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"AL Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier, A. L. et al. The process of Lewy body formation, rather than simply alpha-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc. Natl Acad. Sci. USA 117, 4971\u20134982 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"47027_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00401-018-1829-8","volume":"135","author":"E Luna","year":"2018","unstructured":"Luna, E. et al. Differential alpha-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity. Acta Neuropathol. 135, 855\u2013875 (2018).","journal-title":"Acta Neuropathol."},{"key":"47027_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fninf.2019.00075","volume":"13","author":"SC Yates","year":"2019","unstructured":"Yates, S. C. et al. QUINT: Workflow for quantification and spatial analysis of features in histological images from rodent brain. Front. Neuroinform. 13, 75 (2019).","journal-title":"Front. Neuroinform."},{"key":"47027_CR37","doi-asserted-by":"publisher","first-page":"e0216796","DOI":"10.1371\/journal.pone.0216796","volume":"14","author":"MA Puchades","year":"2019","unstructured":"Puchades, M. A., Csucs, G., Ledergerber, D., Leergaard, T. B. & Bjaalie, J. G. Spatial registration of serial microscopic brain images to three-dimensional reference atlases with the QuickNII tool. PloS one 14, e0216796 (2019).","journal-title":"PloS one"},{"key":"47027_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature05453","volume":"445","author":"ES Lein","year":"2007","unstructured":"Lein, E. S. et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168\u2013176 (2007).","journal-title":"Nature"},{"key":"47027_CR39","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat, C., Nalls, M. A. & Singleton, A. B. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 19, 170\u2013178 (2020).","journal-title":"Lancet Neurol."},{"key":"47027_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28020-5","volume":"13","author":"P Danaher","year":"2022","unstructured":"Danaher, P. et al. Advances in mixed cell deconvolution enable quantification of cell types in spatial transcriptomic data. Nat. Commun. 13, 385 (2022).","journal-title":"Nat. Commun."},{"key":"47027_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41586-021-03465-8","volume":"598","author":"TE Bakken","year":"2021","unstructured":"Bakken, T. E. et al. Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature 598, 111\u2013119 (2021).","journal-title":"Nature"},{"key":"47027_CR42","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1016\/j.cell.2021.04.021","volume":"184","author":"Z Yao","year":"2021","unstructured":"Yao, Z. et al. A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation. Cell 184, 3222\u20133241 e3226 (2021).","journal-title":"Cell"},{"key":"47027_CR43","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41587-022-01483-z","volume":"40","author":"S He","year":"2022","unstructured":"He, S. et al. High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging. Nat. Biotechnol. 40, 1794\u20131806 (2022).","journal-title":"Nat. Biotechnol."},{"key":"47027_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. Nat. methods 18, 100\u2013106 (2021).","journal-title":"Nat. methods"},{"key":"47027_CR45","doi-asserted-by":"publisher","unstructured":"Danaher, P. et al. Insitutype: likelihood-based cell typing for single cell spatial transcriptomics. bioRxiv, https:\/\/doi.org\/10.1101\/2022.10.19.512902 (2022).","DOI":"10.1101\/2022.10.19.512902"},{"key":"47027_CR46","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"47027_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak, H., Ghebremedhin, E., Rub, U., Bratzke, H. & Del Tredici, K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 318, 121\u2013134 (2004).","journal-title":"Cell Tissue Res."},{"key":"47027_CR48","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/mds.10258","volume":"17","author":"V MacDonald","year":"2002","unstructured":"MacDonald, V. & Halliday, G. M. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson\u2019s disease. Mov. Disord. 17, 1166\u20131173 (2002).","journal-title":"Mov. Disord."},{"key":"47027_CR49","doi-asserted-by":"publisher","first-page":"104708","DOI":"10.1016\/j.nbd.2019.104708","volume":"134","author":"LE Stoyka","year":"2020","unstructured":"Stoyka, L. E. et al. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded alpha-synuclein inclusions. Neurobiol. Dis. 134, 104708 (2020).","journal-title":"Neurobiol. Dis."},{"key":"47027_CR50","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41593-022-01041-5","volume":"25","author":"L Gao","year":"2022","unstructured":"Gao, L. et al. Single-neuron projectome of mouse prefrontal cortex. Nat. Neurosci. 25, 515\u2013529 (2022).","journal-title":"Nat. Neurosci."},{"key":"47027_CR51","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson, D. M. et al. Hallmarks of neurodegenerative diseases. Cell 186, 693\u2013714 (2023).","journal-title":"Cell"},{"key":"47027_CR52","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower, J. H. et al. Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136, 2419\u20132431 (2013).","journal-title":"Brain"},{"key":"47027_CR53","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/brain\/aws133","volume":"135","author":"Y Chu","year":"2012","unstructured":"Chu, Y. et al. Alterations in axonal transport motor proteins in sporadic and experimental Parkinson\u2019s disease. Brain 135, 2058\u20132073 (2012).","journal-title":"Brain"},{"key":"47027_CR54","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/mds.27316","volume":"33","author":"P Fazio","year":"2018","unstructured":"Fazio, P. et al. Nigrostriatal dopamine transporter availability in early Parkinson\u2019s disease. Mov. Disord. 33, 592\u2013599 (2018).","journal-title":"Mov. Disord."},{"key":"47027_CR55","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/mds.27823","volume":"34","author":"YC Wong","year":"2019","unstructured":"Wong, Y. C. et al. Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals? Mov. Disord. 34, 1406\u20131422 (2019).","journal-title":"Mov. Disord."},{"key":"47027_CR56","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1091\/mbc.e14-02-0741","volume":"25","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley, L. A. et al. Formation of alpha-synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes. Mol. Biol. cell 25, 4010\u20134023 (2014).","journal-title":"Mol. Biol. cell"},{"key":"47027_CR57","doi-asserted-by":"publisher","first-page":"R633","DOI":"10.1016\/j.cub.2021.02.024","volume":"31","author":"J Aiken","year":"2021","unstructured":"Aiken, J. & Holzbaur, E. L. F. Cytoskeletal regulation guides neuronal trafficking to effectively supply the synapse. Curr. Biol.: CB 31, R633\u2013R650 (2021).","journal-title":"Curr. Biol.: CB"},{"key":"47027_CR58","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3389\/fcell.2020.00787","volume":"8","author":"MI Oliveira da Silva","year":"2020","unstructured":"Oliveira da Silva, M. I. & Liz, M. A. Linking Alpha-Synuclein to the Actin Cytoskeleton: Consequences to neuronal function. Front Cell Dev. Biol. 8, 787 (2020).","journal-title":"Front Cell Dev. Biol."},{"key":"47027_CR59","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H. et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099\u20131109 (2019).","journal-title":"Nat. Neurosci."},{"key":"47027_CR60","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno, L. S. Neuropathology of Parkinson\u2019s disease. J. Neuropathol. Exp. Neurol. 55, 259\u2013272 (1996).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"47027_CR61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/jnc.13266","volume":"139","author":"A Beilina","year":"2016","unstructured":"Beilina, A. & Cookson, M. R. Genes associated with Parkinson\u2019s disease: regulation of autophagy and beyond. J. Neurochem. 139, 91\u2013107 (2016).","journal-title":"J. Neurochem."},{"key":"47027_CR62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldv022","volume":"114","author":"S Mullin","year":"2015","unstructured":"Mullin, S. & Schapira, A. The genetics of Parkinson\u2019s disease. Br. Med Bull. 114, 39\u201352 (2015).","journal-title":"Br. Med Bull."},{"key":"47027_CR63","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jamaneurol.2013.172","volume":"70","author":"KM Doherty","year":"2013","unstructured":"Doherty, K. M. et al. Parkin disease: a clinicopathologic entity? JAMA Neurol. 70, 571\u2013579, (2013).","journal-title":"JAMA Neurol."},{"key":"47027_CR64","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston, J. W., Ballard, P., Tetrud, J. W. & Irwin, I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979\u2013980 (1983).","journal-title":"Science"},{"key":"47027_CR65","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa, J. & Przedborski, S. Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability. Front. Neuroanat. 8, 155 (2014).","journal-title":"Front. Neuroanat."},{"key":"47027_CR66","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonzalez-Rodriguez","year":"2021","unstructured":"Gonzalez-Rodriguez, P. et al. Disruption of mitochondrial complex I induces progressive Parkinsonism. Nature 599, 650\u2013656 (2021).","journal-title":"Nature"},{"key":"47027_CR67","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"Bock, F. J. & Tait, S. W. G. Mitochondria as multifaceted regulators of cell death. Nat. Rev. Mol. Cell Biol. 21, 85\u2013100 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"47027_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0092-8674(03)00509-9","volume":"114","author":"BI Giasson","year":"2003","unstructured":"Giasson, B. I. & Lee, V. M. Are ubiquitination pathways central to Parkinson\u2019s disease? Cell 114, 1\u20138 (2003).","journal-title":"Cell"},{"key":"47027_CR69","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1111\/febs.15617","volume":"288","author":"HE Johnston","year":"2021","unstructured":"Johnston, H. E. & Samant, R. S. Alternative systems for misfolded protein clearance: life beyond the proteasome. FEBS J. 288, 4464\u20134487 (2021).","journal-title":"FEBS J."},{"key":"47027_CR70","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature13418","volume":"510","author":"B Bingol","year":"2014","unstructured":"Bingol, B. et al. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 510, 370\u2013375 (2014).","journal-title":"Nature"},{"key":"47027_CR71","doi-asserted-by":"publisher","first-page":"890823","DOI":"10.3389\/fnagi.2022.890823","volume":"14","author":"LF Silvian","year":"2022","unstructured":"Silvian, L. F. PINK1\/Parkin pathway activation for mitochondrial quality control - which is the best molecular target for therapy? Front. Aging Neurosci. 14, 890823 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"47027_CR72","unstructured":"Vitale, I. et al. Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death Differ. 30, 1097\u20131154 (2023)."},{"key":"47027_CR73","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/BF00427222","volume":"84","author":"T Yamada","year":"1992","unstructured":"Yamada, T., McGeer, P. L. & McGeer, E. G. Lewy bodies in Parkinson\u2019s disease are recognized by antibodies to complement proteins. Acta Neuropathol. 84, 100\u2013104 (1992).","journal-title":"Acta Neuropathol."},{"key":"47027_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-3-29","volume":"3","author":"DA Loeffler","year":"2006","unstructured":"Loeffler, D. A., Camp, D. M. & Conant, S. B. Complement activation in the Parkinson\u2019s disease substantia nigra: an immunocytochemical study. J. Neuroinflamm. 3, 29 (2006).","journal-title":"J. Neuroinflamm."},{"key":"47027_CR75","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/NEN.0b013e31820805b9","volume":"70","author":"C Depboylu","year":"2011","unstructured":"Depboylu, C. et al. Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease. J. Neuropathol. Exp. Neurol. 70, 125\u2013132 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"47027_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01026-0","volume":"8","author":"AJ Schaser","year":"2020","unstructured":"Schaser, A. J. et al. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy. Acta Neuropathol. Commun. 8, 150 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"47027_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47227-z","volume":"9","author":"AJ Schaser","year":"2019","unstructured":"Schaser, A. J. et al. Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders. Sci. Rep. 9, 10919 (2019).","journal-title":"Sci. Rep."},{"key":"47027_CR78","doi-asserted-by":"publisher","first-page":"200296","DOI":"10.1098\/rsob.200296","volume":"11","author":"A Ainslie","year":"2021","unstructured":"Ainslie, A., Huiting, W., Barazzuol, L. & Bergink, S. Genome instability and loss of protein homeostasis: converging paths to neurodegeneration? Open Biol. 11, 200296 (2021).","journal-title":"Open Biol."},{"key":"47027_CR79","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/jnr.21191","volume":"85","author":"Y Nakabeppu","year":"2007","unstructured":"Nakabeppu, Y., Tsuchimoto, D., Yamaguchi, H. & Sakumi, K. Oxidative damage in nucleic acids and Parkinson\u2019s disease. J. Neurosci. Res. 85, 919\u2013934 (2007).","journal-title":"J. Neurosci. Res."},{"key":"47027_CR80","doi-asserted-by":"publisher","first-page":"109668","DOI":"10.1016\/j.celrep.2021.109668","volume":"36","author":"T SenGupta","year":"2021","unstructured":"SenGupta, T. et al. Base excision repair causes age-dependent accumulation of single-stranded DNA breaks that contribute to Parkinson disease pathology. Cell Rep. 36, 109668 (2021).","journal-title":"Cell Rep."},{"key":"47027_CR81","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.neuron.2022.06.021","volume":"110","author":"M Otero-Garcia","year":"2022","unstructured":"Otero-Garcia, M. et al. Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer\u2019s disease. Neuron 110, 2929\u20132948.e2928 (2022).","journal-title":"Neuron"},{"key":"47027_CR82","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41593-022-01222-2","volume":"26","author":"MH Murdock","year":"2023","unstructured":"Murdock, M. H. & Tsai, L. H. Insights into Alzheimer\u2019s disease from single-cell genomic approaches. Nat. Neurosci. 26, 181\u2013195 (2023).","journal-title":"Nat. Neurosci."},{"key":"47027_CR83","doi-asserted-by":"publisher","unstructured":"Geibl, F. F. H., et al. \u03b1-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson\u2019s disease. bioRxiv, https:\/\/doi.org\/10.1101\/2023.12.11.571045 (2023).","DOI":"10.1101\/2023.12.11.571045"},{"key":"47027_CR84","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk, K. C. et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl Acad. Sci. USA 106, 20051\u201320056 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"47027_CR85","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley, L. A., Luk, K. C. & Lee, V. M. Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat. Protoc. 9, 2135\u20132146 (2014).","journal-title":"Nat. Protoc."},{"key":"47027_CR86","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fninf.2020.00037","volume":"14","author":"NE Groeneboom","year":"2020","unstructured":"Groeneboom, N. E., Yates, S. C., Puchades, M. A. & Bjaalie, J. G. Nutil: A pre- and post-processing toolbox for histological rodent brain section images. Front. Neuroinform. 14, 37 (2020).","journal-title":"Front. Neuroinform."},{"key":"47027_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"47027_CR88","doi-asserted-by":"publisher","unstructured":"Henderson, M. X. et al. \u03b1-Synuclein Protein Preparation (Large scale). Protocols.io https:\/\/doi.org\/10.17504\/protocols.io.bp2l6xwmklqe\/v1 (2024)","DOI":"10.17504\/protocols.io.bp2l6xwmklqe\/v1"},{"key":"47027_CR89","doi-asserted-by":"publisher","unstructured":"Henderson, M. X. et al. Stereotaxic Injections. Protocols.io https:\/\/doi.org\/10.17504\/protocols.io.yxmvm3zy5l3p\/v1 (2024).","DOI":"10.17504\/protocols.io.yxmvm3zy5l3p\/v1"},{"key":"47027_CR90","doi-asserted-by":"publisher","unstructured":"Henderson, M. X. et al. Transcardial Perfusion in Mouse. Protocols.io https:\/\/doi.org\/10.17504\/protocols.io.dm6gpbrw1lzp\/v12024.","DOI":"10.17504\/protocols.io.dm6gpbrw1lzp\/v12024"},{"key":"47027_CR91","doi-asserted-by":"publisher","unstructured":"Henderson, M. X. et al. Immunohistochemistry\/Immunofluorescence. Protocols.io https:\/\/doi.org\/10.17504\/protocols.io.5jyl89m9dv2w\/v1 (2024).","DOI":"10.17504\/protocols.io.5jyl89m9dv2w\/v1"},{"key":"47027_CR92","doi-asserted-by":"publisher","unstructured":"Henderson, M. X. et al. Dual In Situ Hybridization\/Immunofluorescence. Protocols.iodx https:\/\/doi.org\/10.17504\/protocols.io.bp2l61n91vqe\/v1 (2024).","DOI":"10.17504\/protocols.io.bp2l61n91vqe\/v1"},{"key":"47027_CR93","doi-asserted-by":"publisher","unstructured":"Henderson, M. X. et al. QUINT Workflow for Fluorescence Protocols.io dx https:\/\/doi.org\/10.17504\/protocols.io.4r3l22y6jl1y\/v1 (2024).","DOI":"10.17504\/protocols.io.4r3l22y6jl1y\/v1"},{"key":"47027_CR94","doi-asserted-by":"publisher","unstructured":"Goralski, T. M. et al. Lewy pathology induced molecular dysfunction. Zenodo https:\/\/doi.org\/10.5281\/zenodo.10729767 (2024).","DOI":"10.5281\/zenodo.10729767"},{"key":"47027_CR95","doi-asserted-by":"publisher","unstructured":"Goralski, T. M. et al. Spatial-transcriptomics-reveals-molecular-dysfunction-associated-with-cortical-Lewy-pathology. Github https:\/\/doi.org\/10.5281\/zenodo.10732492 (2024).","DOI":"10.5281\/zenodo.10732492"},{"key":"47027_CR96","doi-asserted-by":"publisher","unstructured":"Deweerd, D. et al. NutilToUsable. Github https:\/\/doi.org\/10.5281\/zenodo.10626455 (2024).","DOI":"10.5281\/zenodo.10626455"},{"key":"47027_CR97","doi-asserted-by":"publisher","unstructured":"Deweerd, D. et al. ObjectAndRegionSum. Github https:\/\/doi.org\/10.5281\/zenodo.10650925 (2024).","DOI":"10.5281\/zenodo.10650925"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47027-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T02:17:21Z","timestamp":1711419441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47027-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["47027"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-47027-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.05.17.541144","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Daniel Newhouse is an employee and shareholder of NanoString Technologies Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2642"}}